XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019 0            
Beginning balance at Dec. 31, 2019 $ 0            
Ending balance (in shares) at Mar. 31, 2020 0            
Ending balance at Mar. 31, 2020 $ 0            
Beginning balance (in shares) at Dec. 31, 2019     36,678,854        
Beginning balance at Dec. 31, 2019 200,644 $ (119) $ 37 $ 811,049 $ (610,514) $ (119) $ 72
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     1,048,760        
Exercise of stock options 9,046   $ 1 9,045      
Stock-based compensation 8,741     8,741      
Issuance of common stock for settlement of contingent consideration 0            
Issuance of common stock for acquisition consideration (in shares)     110,662        
Issuance of common stock for settlement of contingent consideration 3,332     3,332      
Net Loss (17,490)       (17,490)    
Other comprehensive loss (33)           (33)
Ending balance (in shares) at Mar. 31, 2020     37,838,276        
Ending balance at Mar. 31, 2020 $ 204,121   $ 38 832,167 (628,123)   39
Beginning balance (in shares) at Dec. 31, 2020 0            
Beginning balance at Dec. 31, 2020 $ 0            
Ending balance (in shares) at Mar. 31, 2021 0            
Ending balance at Mar. 31, 2021 $ 0            
Beginning balance (in shares) at Dec. 31, 2020 43,709,237   43,376,848        
Beginning balance at Dec. 31, 2020 $ 276,099   $ 43 1,001,645 (725,650)   61
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units (in shares)     403,971        
Exercise of stock options (in shares) 537,889   537,889        
Exercise of stock options $ 6,488   $ 1 6,487      
Stock-based compensation 13,640     13,640      
Issuance of common stock for settlement of contingent consideration (in shares)     21,328        
Issuance of common stock for settlement of contingent consideration 1,009     1,009      
Issuance of common stock for settlement of contingent consideration 0            
Net Loss (28,370)       (28,370)    
Other comprehensive loss $ (30)           (30)
Ending balance (in shares) at Mar. 31, 2021 44,454,783   44,340,036        
Ending balance at Mar. 31, 2021 $ 268,836   $ 44 $ 1,022,781 $ (754,020)   $ 31